The use of gender-affirming hormone therapy (GAHT) is significantly related to lower rates of depression, suicidal ideation and suicide attempts among transgender and nonbinary youth, according to a ...

CLEVELAND, Ohio (October 12, 2022)—An estimated 71% of transgender women use or intend to use gender-affirming hormone therapy (GAHT). Although sample sizes are comparatively small, there are studies ...

Content warning: This article contains references to suicide. You can click here for a list of resources from the Suicide Prevention Resource Center. New research suggests that gender-affirming ...

Gender-affirming hormone therapies (GAHT) were associated with some cardiac repolarization alterations evident on electrocardiography (ECG), the QTrans cohort study showed. ECG features were reported ...

New research from The Trevor Project found that transgender and nonbinary youth under 18 who received gender-affirming hormone therapy (GAHT) had nearly 40 percent lower odds of depression this past ...

When trans men receive testosterone therapy, their bodies begin to resemble those of cis men in many ways — including their immune systems. That’s according to a study published today in Nature 1, one ...

Future research should investigate the mechanisms underlying the potential relationship between gender-affirming hormone therapy and prostate cancer, according to Deborah C. Marshall, MD. New research ...